Intellia Therapeutics, Inc.
SEC CIK 1652130 · NTLA · last insider filing 2026-06-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Cohen Fred E | Director | filed 2019 - 2026 |
| Verwiel Frank | Director | filed 2017 - 2026 |
| Goff Brian | Director | filed 2024 - 2026 |
| Chase William J | Director | filed 2023 - 2026 |
| Goodman Jesse | Director | filed 2018 - 2026 |
| Keresty Georgia | Director | filed 2021 - 2026 |
| Bhanji Muna | Director | filed 2022 - 2026 |
| Leonard John M. | Director · President and CEO | filed 2016 - 2026 |
| Crowley John F | Director | filed 2020 - 2023 |
| Formela Jean Francois | Director | filed 2016 - 2022 |
| Dorsa Caroline | Director | filed 2016 - 2022 |
| Karsen Perry A | Director | filed 2016 - 2020 |
| Bermingham Nessan | Director · President & CEO | filed 2016 - 2017 |
| Slaoui Moncef | Director | filed 2017 - 2017 |
| Gordon Carl L | Director | filed 2016 - 2017 |
| Isaly Samuel D | Director | filed 2016 - 2016 |
| Orbimed Advisors LLC | Director | filed 2016 - 2016 |
| Orbimed Capital GP V LLC | Director | filed 2016 - 2016 |
| Orbimed Global Healthcare GP LLC | Director | filed 2016 - 2016 |
| Haurwitz Rachel E. | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Basta James | EVP, General Counsel | filed 2021 - 2026 |
| Lebwohl David | EVP, Chief Medical Officer | filed 2020 - 2026 |
| Dulac Edward J III | EVP, Chief Financial Officer | filed 2024 - 2026 |
| Clark Eliana | EVP, Chief Technical Officer | filed 2022 - 2026 |
| Dube Michael P | VP, PAO and Interim PFO | filed 2024 - 2026 |
| Schultes Birgit C | EVP, Chief Scientific Officer | filed 2025 - 2026 |
| Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | filed 2019 - 2025 |
| Hicks Derek | EVP, Chief Business Officer | filed 2021 - 2025 |
| Goddard Glenn | See Remarks | filed 2018 - 2024 |
| Rivera Jose E | EVP, General Counsel & Ops | filed 2016 - 2021 |
| Schiermeier Andrew | See Remarks | filed 2018 - 2021 |
| Hayes John T. | See Remarks | filed 2018 - 2018 |
| Bell Graeme | EVP, Chief Financial Officer | filed 2016 - 2018 |
| Barnes Thomas M. | SVP, R&D eXtellia | filed 2016 - 2017 |
| Morrissey David V | SVP, Platform & Delivery Tech | filed 2016 - 2017 |
| Heifner Nicole | SVP, Accounting | filed 2016 - 2017 |
| Srivastava Sapna | Chief Financial & Stategy Offr | filed 2016 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.